AzTrials
AzTrials

Femoral Neck FractureFR_FNSNCT02422355

A Focused Registry on the Femoral Neck System (FNS) in Patients With Femoral Neck Fractures

An observational study of Femoral Neck Fracture and Hip Fracture, run by AO Innovation Translation Center at 7 sites in 3 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In comparison to previous implants, the Femoral neck system (FNS) is an approved implant by the competent authorities (CE mark). It is designated to stabilize medial femoral neck fractures in a minimal invasive technique. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Femoral Neck Fracture, Hip Fracture
What is being tested?
FNS
Type of treatment
Medical device
How many people
125 participants
Where
7 sitesin 3 countries
Study dates
30 Sep 2017to 31 Dec 2021
How long will I take part?
12 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients suffering from a femoral neck fracture (AO/OTA 31-B1:3) with the need of a fixation using the FNS.

Who may be able to join

  • Age 18 years and older
  • Diagnosis of a medial femoral neck fracture (AO/OTA 31-B1:3) with the need of a fixation using the FNS.
  • Ability to understand the content of the patient information/Informed Consent Form
  • Willingness and ability to participate in the registry according to the Registry Plan (RP)
  • Signed and dated Ethics Committee (EC)/Institutional Review Board (IRB) approved written informed consent

Who cannot join

  • Pathological fracture
  • Additional acute fracture
  • Any not medically managed severe systemic disease
  • Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the registry period
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present registry

Trial locations and contacts

7 sites in 3 countries.

7 sites in 3 countries

Switzerland4 sites
  • Kantonsspital Baselland

    Bruderholz, Basel-Landschaft, 4401

  • Luzerner Kantonsspital

    Lucerne, 6006

  • Ospedale Regionale di Lugano

    Lugano, Canton Ticino, 6900

  • Stadtspital Triemli

    Zurich, 8063

Other trials in Switzerland

Germany2 sites
  • Friedrich-Schiller-Universität Jena

    Jena, Thuringia, 07740

  • Ulm University

    Ulm, Baden-Wurttemberg, 89081

Other trials in Germany

Austria1 site
  • Medizinische Universität Innsbruck

    Innsbruck, Tyrol, 6020

Other trials in Austria

About this study

In comparison to previous implants, the Femoral neck system (FNS) is an approved implant by the competent authorities (CE mark). It is designated to stabilize medial femoral neck fractures in a minimal invasive technique. The implant combines an angular stable device with screw in screw technology for rotational stability. Therefore the purpose of this focused registry is to investigate how the newly developed and approved implant called FNS is performing clinically and radiologically in terms of surgical technique, intra- and postoperative complications and short term outcome.

Read the detailed description

All patients included are treated as per standard or care and followed up from the time point of enrollment until at least three months after surgery as described below. Data of a visit after 6 months and 12 months are collected if bone union according to the RUSH score is not complete after 3 or 6 months respectively or if the patient has persistent or increasing pain on the operated site.

Preoperative:

  • Patient details
  • Fracture Classification and comminution based on CT
  • Pre-fracture HHS and EQ5D
  • X-rays

Intraoperative:

  • Surgery details
  • Defined intraoperative complications
  • Intraoperative fluoroscopy: hip ap (with leg 15° internally rotated) and lateral after reduction and after implant placement

Postoperative:

  • X-ray prior to any mechanical load: hip ap (with leg 15° internally rotated) and lateral 6 weeks and 3 months FU:
  • Defined postoperative complications
  • HSS and EQ5D
  • X-rays
Being tested
FNS
Keywords
hip, femoral neck, Garden classification, healing, cut-out, iatrogenic fracture, implant, rotational stability, minimal invasive
Medical subject headings
Femoral Neck Fractures, Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FNSDevice

    Surgical intervention using the FNS

Study groups in NCT02422355
Study groupRoleWhat they receive
Femoral Neck Fractures AO/OTA 31-B1:3Fixation using the implant FNS.
Receives: Device: FNS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of complications within the first 3 months after surgery

    Measured: 3 months

Secondary outcomes (8)
  1. Fracture mechanism

    Classification of the fracture mechanism in one of the following group: Fall from standing height , Falls from elevated height, Road traffic accident or Other causes

    Measured: Pre-operatively (Day -1)

  2. Classification of the fracture

    Classification of the fracture using the Garden classification and the AO/AOTA classification

    Measured: Pre-operatively (Day -1)

  3. Time from injury to surgery

    Time in hours from the injury to the start of the surgery

    Measured: Surgery (Day 0)

  4. Length of surgery

    Time in minutes from first incision to closure

    Measured: Surgery (Day 0)

  5. Harris Hip Score

    Measured: Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery

  6. EQ5D-5L

    Measured: Pre-operatively (Day -1), 6 weeks, 3 months, 6 months and 12 months after surgery

  7. Radiological bone union (RUSH score)

    RUSH score

    Measured: 6 weeks, 3 months, 6 months and 12 months after surgery

  8. Quality of reduction (Garden's alignment index and Lowell's criteria)

    Garden's alignment index and Lowell's criteria

    Measured: Surgery (Day 0)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2015 (estimated)
  2. Study start30 Sep 2017
  3. Primary completion30 Nov 2020
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
125 participants (actual)
Target duration
12 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT02422355
Sponsor's protocol ID
FR FNS
Acronym
FR_FNS
Status last verified
Dec 2021
First submitted
27 Mar 2015
Last updated
31 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Stoffel K, Michelitsch C, Arora R, Babst R, Candrian C, Eickhoff A, Gebhard F, Platz A, Schmid FA, Weschenfelder W, Sommer C. Clinical performance of the Femoral Neck System within 1 year in 125 patients with acute femoral neck fractures, a prospective observational case series. Arch Orthop Trauma Surg. 2023 Jul;143(7):4155-4164. doi: 10.1007/s00402-022-04686-w. Epub 2022 Dec 2.

    PubMed 36460761

Questions about this trial

What is this clinical trial studying?

An observational study of Femoral Neck Fracture and Hip Fracture, run by AO Innovation Translation Center at 7 sites in 3 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in Switzerland, Germany, Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of complications within the first 3 months after surgery (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02422355, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in